Raman Microspectroscopic Evidence for the Metabolism of a Tyrosine Kinase Inhibitor, Neratinib, in Cancer Cells

Tyrosine kinase receptors are one of the main targets in cancer therapy. They play an essential role in the modulation of growth factor signaling and thereby inducing cell proliferation and growth. Tyrosine kinase inhibitors such as neratinib bind to EGFR and HER2 receptors and exhibit antitumor act...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Angew Chem Int Ed Engl
Egile Nagusiak: Aljakouch, Karim, Lechtonen, Tatjana, Yosef, Hesham K., Hammoud, Mohamad K., Alsaidi, Wissam, Kötting, Carsten, Mügge, Carolin, Kourist, Robert, El‐Mashtoly, Samir F., Gerwert, Klaus
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: John Wiley and Sons Inc. 2018
Gaiak:
Communications
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6033014/
https://ncbi.nlm.nih.gov/pubmed/29645336
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/anie.201803394
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak